Empyrean Medical Systems, Inc.
Empyrean Medical Systems is a pioneering company dedicated to revolutionizing cancer treatment through its three core divisions: research and clinical devices, therapeutics, and informatics. Leveraging expertise in quantum physics, molecular biology, chemistry, and machine learning, Empyrean aims to deliver accurate and safe solutions for cancer treatment and research. The company was founded in 2020 by CEO Kal Fishman, inspired by personal tragedy, with a mission to develop novel oncology products and solutions that improve patient outcomes worldwide. Empyrean has a pipeline of disruptive products and a team of experts focused on advancing cancer care.
Empyrean Medical Systems, Inc.
Empyrean Medical Systems is a pioneering company dedicated to revolutionizing cancer treatment through its three core divisions: research and clinical devices, therapeutics, and informatics. Leveraging expertise in quantum physics, molecular biology, chemistry, and machine learning, Empyrean aims to deliver accurate and safe solutions for cancer treatment and research. The company was founded in 2020 by CEO Kal Fishman, inspired by personal tragedy, with a mission to develop novel oncology products and solutions that improve patient outcomes worldwide. Empyrean has a pipeline of disruptive products and a team of experts focused on advancing cancer care.